bioRxivImmunology
Cold Exposure Protects from Neuroinflammation Through Immunologic Reprogramming
M. Spiljar, K. Steinbach, D. Rigo, N. Suarez-Zamorano, I. Wagner, N. Hadadi, I. Vincenti, N. Page, B. Klimek, M.-A. Rochat, M. Kreutzfeldt, C. Chevalier, O. Stojanovic, M. Mack, D. Cansever, M. Greter, D. Merkler, M. Trajkovski
Abstract
Autoimmunity is energetically costly, but the impact of a metabolically active state on immunity and immune-mediated diseases is unclear. Ly6Chi monocytes are key effectors in CNS autoimmunity with elusive role in priming naive autoreactive T cells. Here we provide unbiased analysis of the immune changes in various compartments during cold exposure, and show that this energetically costly stimulus markedly ameliorates active experimental autoimmune encephalomyelitis (EAE). Cold exposure decreases MHCII on monocytes at steady-state and in various inflammatory mouse models, and suppresses T cell priming and pathogenicity through the modulation of monocytes. Genetic, or antibody-mediated monocyte depletion, or adoptive transfer of Th1- or Th17-polarized cells for EAE abolish the cold-induced effects on T cells or EAE, respectively. These findings provide a mechanistic link between environmental temperature and neuroinflammation, and suggest competition between cold-induced metabolic adaptations and autoimmunity as energetic trade-off beneficial for the immune-mediated diseases.
- organism: mouse
- assay: bulk RNA-seq
- research focus: host-pathogen & immune response
- research focus: cell signaling & trafficking
- research focus: differential expression
- research focus: cell type annotation
- approach: experimental assay
- approach: genetic perturbation / CRISPR
- approach: wet-lab / biochemical assay
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Interleukin-19 alleviates experimental autoimmune encephalomyelitis by attenuating antigen-presenting cell activation
H. Horiuchi, B. Parajuli, … H. Takeuchi·bioRxiv·Jul 15, 2020
- The innate cytokine IL-18 inhibits CNS autoimmunity through preferential activation of protective CD8 T-cells
Jeremy A. Morrissette, Vinh Dang, … Scott Canna·bioRxiv·Jan 28, 2026
- Increased activity of IRE1 improves the clinical presentation of EAE
Valerie C. Bracchi-Ricard, Kayla Nguyen, … Yair Argon·The FASEB JournalPeer-reviewed·Nov 20, 2023
- Dectin-1 limits central nervous system autoimmunity through a non-canonical pathway
M. E. Deerhake, K. Danzaki, … M. L. Shinohara·bioRxiv·May 6, 2020
- CSF-1 maintains pathogenic but not homeostatic myeloid cells in the central nervous system during autoimmune neuroinflammation.
D. Hwang, L. L. W. Ishiwaka, … B. Ciric·bioRxiv·Oct 23, 2020
- Age related susceptibility to grey matter demyelination and neurodegeneration is associated with meningeal neutrophil accumulation in an animal model of Multiple Sclerosis
M. Zuo, N. Fettig, … V. Ramaglia·bioRxiv·Dec 23, 2021